Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
URL: http://www.news-medical.net/news/20130205/GLP-1-receptor-agonists-associated-with-reduced-BMI-in-adolescents-with-severe-obesity.aspx
No comments:
Post a Comment